Delivery Order SPE2DB20D2104-SPE2DB24FT61X
- Not listed
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,287.15 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and was awarded on April 16, 2025, with a completion date of April 17, 2025....
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $37,588.28. The contract has an ultimate completion date of January 26, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, on January 8, 2024. The contract has a ceiling value of $3,041.01 and a completion date of January 9, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $8,687.77 and a period of performance through January 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,377.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,131.69, is a Firm Fixed Price Delivery Order that runs through November 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 4560895403 MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $9,587.31 and an ultimate completion date of May 11, 2023. It is a firm fixed-price delivery order contract and was not set aside for any specific business category. Amerisourcebergen holds a...
- This federal contract award is for the supply of the pharmaceutical product MULTAQ 400 MG TABLET 60S to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $6,173.47 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $23,146.08 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 14, 2021 and was not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the Defense Logistics Agency (DLA), a key agency within the U.S. Department of Defense. The $38,782.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2022 and was not set aside for any specific business type, indicating open competition....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT61XDelivery Order
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,381.11 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 16, 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 4/15/24 |